Aromatase inhibitor-induced carpal tunnel syndrome: prevalence in daily practice.

Introduction: We aim to evaluate prevalence and characteristics of CTS in routine daily practice over a 5-year period, with a review of the literature.

Methods: Patients treated with endocrine therapy (441) were retrospectively analyzed looking for CTS cases in aromatase inhibitors (219, 49.6%) and in tamoxifen (222, 50.